AMIGO-Kv2.1 Potassium Channel Complex Is Associated With Schizophrenia-Related Phenotypes.

The enormous variability in electrical properties of neurons is largely affected by a multitude of potassium channel subunits. Kv2.1 is a widely expressed voltage-dependent potassium channel and an important regulator of neuronal excitability. The Kv2.1 auxiliary subunit AMIGO constitutes an integral part of the Kv2.1 channel complex in brain and regulates the activity of the channel. AMIGO and Kv2.1 localize to the distinct somatodendritic clusters at the neuronal plasma membrane. Here we have created and characterized a mouse line lacking the AMIGO gene. Absence of AMIGO clearly reduced the amount of the Kv2.1 channel protein in mouse brain and altered the electrophysiological properties of neurons. These changes were accompanied by behavioral and pharmacological abnormalities reminiscent of those identified in schizophrenia. Concomitantly, we have detected an association of a rare, population-specific polymorphism of KV2.1 (KCNB1) with human schizophrenia in a genetic isolate enriched with schizophrenia. Our study demonstrates the involvement of AMIGO-Kv2.1 channel complex in schizophrenia-related behavioral domains in mice and identifies KV2.1 (KCNB1) as a strong susceptibility gene for schizophrenia spectrum disorders in humans.

[1]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[2]  Andres Metspalu,et al.  Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population , 2014, PLoS genetics.

[3]  C. Tamminga,et al.  Kv3.1-containing K+ channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs , 2014, Molecular Psychiatry.

[4]  Jon T. Sack,et al.  Deletion of the Kv2.1 delayed rectifier potassium channel leads to neuronal and behavioral hyperexcitability , 2014, Genes, brain, and behavior.

[5]  Alejandro A. Schäffer,et al.  PSEUDOMARKER 2.0: efficient computation of likelihoods using NOMAD , 2014, BMC Bioinformatics.

[6]  I. McGregor,et al.  A novel automated test battery reveals enduring behavioural alterations and cognitive impairments in survivors of murine pneumococcal meningitis , 2014, Brain, Behavior, and Immunity.

[7]  Dongxu Guan,et al.  Kv2 channels regulate firing rate in pyramidal neurons from rat sensorimotor cortex , 2013, The Journal of physiology.

[8]  P. Gass,et al.  Rodent models of psychiatric disorders—practical considerations , 2013, Cell and Tissue Research.

[9]  M. Jarvelin,et al.  Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders , 2013, Nature Neuroscience.

[10]  C. Schroeder,et al.  Predictive Suppression of Cortical Excitability and Its Deficit in Schizophrenia , 2013, The Journal of Neuroscience.

[11]  S. Jalkanen,et al.  CD73 Is a Major Regulator of Adenosinergic Signalling in Mouse Brain , 2013, PloS one.

[12]  J. Waddington,et al.  Genetic models of schizophrenia and related psychotic disorders: progress and pitfalls across the methodological “minefield” , 2013, Cell and Tissue Research.

[13]  S. Miyamoto,et al.  Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents , 2012, Molecular Psychiatry.

[14]  D. Weinberger,et al.  Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophrenia. , 2012, The American journal of psychiatry.

[15]  B. Morris,et al.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap , 2012, Nature Reviews Drug Discovery.

[16]  I. Rosenzweig,et al.  Abnormalities in thalamic neurophysiology in schizophrenia: Could psychosis be a result of potassium channel dysfunction? , 2012, Neuroscience & Biobehavioral Reviews.

[17]  J. Kuja-Panula,et al.  AMIGO is an auxiliary subunit of the Kv2.1 potassium channel , 2011, EMBO reports.

[18]  D. Collier,et al.  Translational Neuroscience of Schizophrenia: Seeking a Meeting of Minds Between Mouse and Man , 2011, Science Translational Medicine.

[19]  H. Rauvala,et al.  Evaluation of Social and Physical Enrichment in Modulation of Behavioural Phenotype in C57BL/6J Female Mice , 2011, PloS one.

[20]  Alejandro A. Schäffer,et al.  PSEUDOMARKER: A Powerful Program for Joint Linkage and/or Linkage Disequilibrium Analysis on Mixtures of Singletons and Related Individuals , 2011, Human Heredity.

[21]  M. Vogt,et al.  APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP , 2011, The EMBO journal.

[22]  S. Hyman,et al.  Animal models of neuropsychiatric disorders , 2010, Nature Neuroscience.

[23]  W. Singer,et al.  Abnormal neural oscillations and synchrony in schizophrenia , 2010, Nature Reviews Neuroscience.

[24]  Heike Wulff,et al.  Voltage-gated potassium channels as therapeutic targets , 2009, Nature Reviews Drug Discovery.

[25]  D. Snyders,et al.  Kv2.1 and silent Kv subunits underlie the delayed rectifier K+ current in cultured small mouse DRG neurons. , 2009, American journal of physiology. Cell physiology.

[26]  D. Rujescu,et al.  A novel, primate-specific, brain isoform of KCNH2 impacts cortical physiology, cognition, neuronal repolarization and risk for schizophrenia , 2009, Nature Medicine.

[27]  C. Bundgaard,et al.  Antipsychotic-Like Effect of Retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic Acid Ester], a KCNQ Potassium Channel Opener, via Modulation of Mesolimbic Dopaminergic Neurotransmission , 2009, Journal of Pharmacology and Experimental Therapeutics.

[28]  M. Keshavan,et al.  Schizophrenia, “just the facts”: What we know in 2008 Part 3: Neurobiology , 2008, Schizophrenia Research.

[29]  J. Suvisaari,et al.  Geographic variation and sociodemographic characteristics of psychotic disorders in Finland , 2008, Schizophrenia Research.

[30]  M. Tamkun,et al.  The Kv2.1 K+ channel targets to the axon initial segment of hippocampal and cortical neurons in culture and in situ , 2008, BMC Neuroscience.

[31]  J. Trimmer,et al.  Localization and targeting of voltage-dependent ion channels in mammalian central neurons. , 2008, Physiological reviews.

[32]  S. Thompson,et al.  Dynamic Regulation of the Kv2.1 Voltage-Gated Potassium Channel during Brain Ischemia through Neuroglial Interaction , 2008, The Journal of Neuroscience.

[33]  W. Carpenter,et al.  The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities , 2008, Neuropsychopharmacology.

[34]  J A Veltman,et al.  CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy , 2008, Molecular Psychiatry.

[35]  D. Surmeier,et al.  Kv2 subunits underlie slowly inactivating potassium current in rat neocortical pyramidal neurons , 2007, The Journal of physiology.

[36]  L. Cavarec,et al.  PP2A-Bγ subunit and KCNQ2 K+ channels in bipolar disorder , 2007, The Pharmacogenomics Journal.

[37]  T. Miyakawa,et al.  Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder? , 2006, Biological Psychiatry.

[38]  M. Saarma,et al.  In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered , 2006, Synapse.

[39]  J. Trimmer,et al.  Calcium- and Metabolic State-Dependent Modulation of the Voltage-Dependent Kv2.1 Channel Regulates Neuronal Excitability in Response to Ischemia , 2005, The Journal of Neuroscience.

[40]  J. Trimmer,et al.  Kv2.1: a voltage-gated k+ channel critical to dynamic control of neuronal excitability. , 2005, Neurotoxicology.

[41]  J. Suvisaari,et al.  Prevalence and diagnosis of schizophrenia based on register, case record and interview data in an isolated Finnish birth cohort born 1940–1969 , 2005, Social Psychiatry and Psychiatric Epidemiology.

[42]  D. Surmeier,et al.  A mechanism for homeostatic plasticity , 2004, Nature Neuroscience.

[43]  James S Trimmer,et al.  Regulation of ion channel localization and phosphorylation by neuronal activity , 2004, Nature Neuroscience.

[44]  C. Austin,et al.  Expression of voltage-gated potassium channels in human and rhesus pancreatic islets. , 2004, Diabetes.

[45]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[46]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[47]  J. Kuja-Panula,et al.  AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats , 2003, The Journal of cell biology.

[48]  S. Akhondzadeh,et al.  Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia * , 2002, Journal of clinical pharmacy and therapeutics.

[49]  J D Terwilliger,et al.  Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. , 2001, Human molecular genetics.

[50]  Daniel R Weinberger,et al.  To Model a Psychiatric Disorder in Animals: Schizophrenia As a Reality Test , 2000, Neuropsychopharmacology.

[51]  H H Göring,et al.  Linkage analysis in the presence of errors IV: joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified. , 2000, American journal of human genetics.

[52]  M. Tsuang,et al.  Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. , 2000, The American journal of psychiatry.

[53]  C. McBain,et al.  Frequency‐dependent regulation of rat hippocampal somato‐dendritic excitability by the K+ channel subunit Kv2.1 , 2000, The Journal of physiology.

[54]  J. Suvisaari,et al.  A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. , 1999, American journal of human genetics.

[55]  D. Surmeier,et al.  Delayed Rectifier Currents in Rat Globus Pallidus Neurons Are Attributable to Kv2.1 and Kv3.1/3.2 K+ Channels , 1999, The Journal of Neuroscience.

[56]  J. Trimmer,et al.  Identification of the Kv2.1 K+ Channel as a Major Component of the Delayed Rectifier K+ Current in Rat Hippocampal Neurons , 1999, The Journal of Neuroscience.

[57]  C. McBain,et al.  The K+ channel, Kv2.1, is apposed to astrocytic processes and is associated with inhibitory postsynaptic membranes in hippocampal and cortical principal neurons and inhibitory interneurons , 1998, Neuroscience.

[58]  A. Bergen,et al.  Identification of a Ser857-Asn857 substitution in DRK1 (KCNB1), population frequencies and lack of association to the low voltage alpha EEG trait , 1996, Human Genetics.

[59]  Tyrone D. Cannon,et al.  A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. , 2000, Schizophrenia bulletin.